Clinical advice to Cancer Alliances for the provision of Breast Cancer Services

The 2017 publication from the Breast Cancer Clinical Expert Group is not a guidance document per se but instead a list of best practice recommendations to commissioners and acute trusts for a modern breast service. The publication is intended to be used to benchmark existing services. It includes a recommendation that bisphosphonates should be offered to postmenopausal women “to reduce the risk of bone recurrence and fractures, and improve breast cancer survival”

Classifications: Adjuvant & Neoadjuvant Treatment

Keywords: Bisphosphonates Service Guidance Breast Cancer Services